Coronary Artery Disease Clinical Trial
— IMPACT-CTOOfficial title:
The Physiological IMPACT of Coronary Chronic Total Occlusion (CTO) Percutaneous Coronary Intervention (PCI) on Coronary Pressure --Derived Measurements, Its Correlation in the Donor Vessel and the Influence of Collateral Circulation
| NCT number | NCT02643940 |
| Other study ID # | B785 |
| Secondary ID | |
| Status | Completed |
| Phase | |
| First received | |
| Last updated | |
| Start date | October 1, 2015 |
| Est. completion date | May 31, 2018 |
| Verified date | December 2021 |
| Source | Mid and South Essex NHS Foundation Trust |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
This study will be recording pressure wire readings from both blocked and narrowed arteries, to better guide treatment options; medications, stents or potentially bypass surgery, for patients with Chronic Total Occlusion (CTO).
| Status | Completed |
| Enrollment | 42 |
| Est. completion date | May 31, 2018 |
| Est. primary completion date | May 31, 2018 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: 1. Age >18 years of age 2. Stable angina / ischaemic symptoms 3. Evidence of viability and / or ischaemia in the chronic total occlusion (CTO) territory 4. Participant is willing and able to give informed consent for participation in the study 5. Presence of a chronic total occlusion (CTO) in RCA: - Duration of the occlusion > 3 months; - Thrombolysis In Myocardial Infarction (TIMI) (50) coronary flow grade 0; - Spontaneously visible collaterals, Rentrop classification grade 1 or 2 or 3 from contralateral donor artery 6. Presence of minor to intermediate coronary stenosis (1-70 %) in the contralateral donor artery 7. Eligible for PCI to a chronic total occlusion (CTO) Exclusion Criteria: 1. Previous CABG with patent grafts to the interrogated donor artery 2. Left main stenosis of > 40 % 3. Presence of severe flow limiting stenosis in the contralateral donor artery (typically > 70 % stenosis) 4. Haemodynamic instability at the time of intervention (heart rate <40 beats per minute, systolic blood pressure <90mmHg), balloon pump) 5. Significant contraindication to adenosine administration (e.g. heart block, severe asthma) 6. Contraindications to PCI 7. Severe hepatic or lung disease (chronic pulmonary obstructive disease) 8. Pregnancy 9. ACS within 48 hours of procedure 10. Severe valvular heart disease 11. Severe cardiomyopathy / Infiltrative heart disease 12. eGFR < 40 |
| Country | Name | City | State |
|---|---|---|---|
| United Kingdom | The Essex Cardiothoracic Centre | Basildon | Essex |
| Lead Sponsor | Collaborator |
|---|---|
| Mid and South Essex NHS Foundation Trust |
United Kingdom,
Karamasis GV, Kalogeropoulos AS, Mohdnazri SR, Al-Janabi F, Jones R, Jagathesan R, Aggarwal RK, Clesham GJ, Tang KH, Kelly PA, Davies JR, Werner GS, Keeble TR. Serial Fractional Flow Reserve Measurements Post Coronary Chronic Total Occlusion Percutaneous — View Citation
Mohdnazri SR, Karamasis GV, Al-Janabi F, Cook CM, Hampton-Till J, Zhang J, Al-Lamee R, Dungu JN, Gedela S, Tang KH, Kelly PA, Davies JE, Davies JR, Keeble TR. The impact of coronary chronic total occlusion percutaneous coronary intervention upon donor ves — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Coronary pressure changes | Changes in coronary pressure - derived measurements (resting Pd/Pa, iFR and FFR) in donor artery pre and post RCA CTO PCI | 5 Minutes | |
| Secondary | Population correlation | Correlation between coronary pressure---derived measurements in this population. | 5 minutes | |
| Secondary | Donor artery correlation | Correlation between collateral circulation function on coronary pressure - derived measurements in donor artery pre and post RCA CTO PCI. | 5 minutes | |
| Secondary | Cardiac MRI correlation | Correlation between baseline coronary pressure - derived measurements in donor artery pre RCA CTO PCI, collateral circulation indices and baseline non-invasive functional assessment /Cardiac MRI (CMR) | 5 minutes | |
| Secondary | Effects of stenosis severity (QCA) | Effects of stenosis severity (QCA) in donor artery on coronary pressure-derived measurements | 5 minutes | |
| Secondary | Collateral circulation characteristics | Influence of collateral circulation characteristics on coronary pressure-derived measurements | 5 minutes | |
| Secondary | Coronary pressure and jeopardy scores correlation | Correlation between coronary pressure-derived measurements in the donor artery and myocardial jeopardy scores in the donor artery | 5 minutes |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06030596 -
SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
|
||
| Completed |
NCT04080700 -
Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
|
||
| Recruiting |
NCT03810599 -
Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study
|
N/A | |
| Recruiting |
NCT06002932 -
Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions.
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT05308719 -
Nasal Oxygen Therapy After Cardiac Surgery
|
N/A | |
| Recruiting |
NCT04242134 -
Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions
|
N/A | |
| Completed |
NCT04556994 -
Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients.
|
N/A | |
| Recruiting |
NCT05846893 -
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
|
N/A | |
| Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
| Recruiting |
NCT05023629 -
STunning After Balloon Occlusion
|
N/A | |
| Completed |
NCT04941560 -
Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
|
||
| Completed |
NCT04006288 -
Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
|
Phase 4 | |
| Completed |
NCT01860274 -
Meshed Vein Graft Patency Trial - VEST
|
N/A | |
| Recruiting |
NCT06174090 -
The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients
|
N/A | |
| Terminated |
NCT03959072 -
Cardiac Cath Lab Staff Radiation Exposure
|
||
| Completed |
NCT03968809 -
Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
|
||
| Recruiting |
NCT05065073 -
Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography
|
Phase 4 | |
| Recruiting |
NCT04566497 -
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
|
N/A | |
| Completed |
NCT05096442 -
Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions
|
N/A |